blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1844018

EP1844018 - CRYSTALLINE FORMS FENOLDOPAM MESYLATE [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  24.07.2009
Database last updated on 16.11.2024
Most recent event   Tooltip24.07.2009Application deemed to be withdrawnpublished on 26.08.2009  [2009/35]
Applicant(s)For all designated states
Sicor Inc.
19 Hughes
Irvine, CA 92618 / US
[2007/42]
Inventor(s)01 / MACDONALD, Peter, Lindsey
Via Rubiana, 14
CH-Gentilino / CH
02 / BIGATTI, Ettore
P.zza Tarchini, 67
CH-Balerna / CH
03 / ROSSETTO, Pierluigi
P.zza Tarchini, 67
CH-Balerna / CH
04 / ARONHIME, Judith
5a Harav Maor Yosef Street
76217 Rehovot / IL
05 / LEVI, Sigalit
87 Shimon Street
Modi'in / IL
 [2007/42]
Representative(s)Wong, Kit Yee, et al
D Young & Co LLP
120 Holborn
London EC1N 2DY / GB
[N/P]
Former [2007/42]Wong, Kit Yee, et al
D Young & Co 120 Holborn
London EC1N 2DY / GB
Application number, filing date06789776.915.08.2006
[2007/42]
WO2006US31815
Priority number, dateUS20050708739P15.08.2005         Original published format: US 708739 P
[2007/42]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2007022173
Date:22.02.2007
Language:EN
[2007/08]
Type: A2 Application without search report 
No.:EP1844018
Date:17.10.2007
Language:EN
The application published by WIPO in one of the EPO official languages on 22.02.2007 takes the place of the publication of the European patent application.
[2007/42]
Search report(s)International search report - published on:EP07.09.2007
ClassificationIPC:C07D233/16, A61K31/50, A61P9/12
[2007/42]
CPC:
C07D223/16 (EP,KR,US); A61K31/55 (KR); A61P9/12 (EP);
C07D233/16 (EP,KR,US); C07B2200/13 (KR)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2007/42]
Extension statesRSNot yet paid
TitleGerman:KRISTALLINE FORMEN VON FENOLDOPAM-MESYLAT[2007/42]
English:CRYSTALLINE FORMS FENOLDOPAM MESYLATE[2007/42]
French:FORMES CRISTALLINES DU MÉSYLATE DE FENOLDOPAM[2007/42]
Entry into regional phase29.03.2007National basic fee paid 
29.03.2007Designation fee(s) paid 
29.03.2007Examination fee paid 
Examination procedure30.03.2007Amendment by applicant (claims and/or description)
30.03.2007Examination requested  [2007/42]
01.12.2008Despatch of a communication from the examining division (Time limit: M04)
02.03.2009Application deemed to be withdrawn, date of legal effect  [2009/35]
07.04.2009Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2009/35]
Fees paidPenalty fee
Additional fee for renewal fee
31.08.200803   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]US2004057987  (VAN OSDOL WILLIAM W [US], et al) [X] 1-21,39-66,22-38,64-66 * page 1, paragraph [0001];; example 1; claims 1-36 *;
 [X]WO9955341  (ELAN PHARM INC [US]) [X] 1-21,39-66,22-38,64-66 * passage bridging pages 8 and 9; tables 2-4; page 1, line 9 - page 1, line 29; examples 1-3; claim - *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.